FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|May 19, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of May 19, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 47.9% of total US population has received at least 1 dose
• 37.8% of total US population is fully vaccinated
• 37.8% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 50.1%
2. Connecticut: 49.3%
3. Vermont: 48.4%
4. Rhode Island: 48%
5. Massachusetts: 47.7%
2. Connecticut: 49.3%
3. Vermont: 48.4%
4. Rhode Island: 48%
5. Massachusetts: 47.7%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 33 016 539 confirmed cases
• 587 640 deaths
• 587 640 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 771 606
2. Texas: 2 935 112
3. Florida: 2 299 478
4. New York: 2 089 698
5. Illinois: 1 370 247
2. Texas: 2 935 112
3. Florida: 2 299 478
4. New York: 2 089 698
5. Illinois: 1 370 247
Deaths: California has the most deaths due to COVID-19 with 62 745 reported fatalities, followed by New York with 53 044, and Texas with 51 016.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 164 431 521 confirmed cases, 3 408 536 deaths, and 1 534 197 692 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
2
Type 2 Diabetes, Genetic Risk Linked to MASLD Cirrhosis Before Age 50
3
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
4
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
5